ALPS Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

ALPS Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-50,218	Closed	-$8.68M	–	978
2018 Q3	$8.68M	Buy	50,218 +13,695	+37%	+$1.97M	0.06%	126
2018 Q2	$5.1M	Buy	36,523 +2,583	+8%	+$367K	0.03%	169
2018 Q1	$3.82M	Buy	33,940 +5,899	+21%	+$742K	0.03%	167
2017 Q4	$3.7M	Buy	28,041 +3,120	+13%	+$367K	0.03%	152
2017 Q3	$2.53M	Buy	24,921 +2,081	+9%	+$223K	0.02%	173
2017 Q2	$2.29M	Buy	22,840 +1,071	+5%	+$115K	0.02%	176
2017 Q1	$2.63M	Sell	21,769 -1,973	-8%	-$242K	0.02%	161
2016 Q4	$2.65M	Buy	+23,742	New	+$2.86M	0.02%	164

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ALPS Advisors's GWPH Position: Q4 2018 in Review

ALPS Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018, closing a stake of 50,218 shares — an estimated $8.68M sold.

ALPS Advisors first reported a position in GWPH in Q4 2016 and held it in 8 quarters. The position peaked at $8.68M in Q3 2018. 277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

ALPS Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
ALPS Advisors sold 50,218 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2018, an estimated $8.68M.
ALPS Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 8 quarters.
ALPS Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $8.68M in Q3 2018.
277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on ALPS Advisors's 13F filing for Q4 2018, filed 4 Feb 2019.